Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative oxycodone to reduce pain and promote rehabilitation after total knee arthroplasty
ChiCTR2600116918Phase 4Not yet recruiting
- Sponsor
- The Fifth Affiliated Hospital of Zhengzhou University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in knee osteoarthritis (OA) and osteoarthritis (OA) (2 arms), sponsored by The Fifth Affiliated Hospital of Zhengzhou University. Primary endpoints: Static visual analogue scale (VAS) pain score at rest, Dynamic visual analogue scale (VAS) pain score during knee movement and 3 more. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2600116918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116918.